These findings suggest that in BC, BRCA1 mutation results in higher HRD scores than BRCA2 mutation, further supporting the existence of differences between BRCA1 and BRCA2 germline mutations in the induction of genomic instability. The gene discussed is BRCA1; the disease is breast cancer.